U.S. Congressional investigators said Wednesday that Chinese opioid manufacturers are exploiting weak screening at the U.S. Postal Service to ship large quantities of illegal drugs to American dealers.
In a yearlong probe, Senate investigators found that Chinese sellers, who openly market opioids such as fentanyl to U.S. buyers, are pushing delivery through the U.S. postal system. The sellers are taking advantage of a failure by the postal service to fully implement an electronic data system that would help authorities identify suspicious shipments.
At a time of massive growth in postal shipments from China due to e-commerce, the investigators found that the postal system received the electronic data on just over a third of all international packages, making more than 300 million packages in 2017 much harder to screen. Data in the Senate report shows no significant improvement during 2017 despite the urgency. (Read more from “Opioid Sellers in China Exploit U.S. Postal Service Flaw” HERE)